We next examined whether UBE2T overexpression was associated with prognosis and found that breast cancer samples with higher UBE2T expression levels were associated with shorter on relapse-free survival and (RFS) and shorter overall survival (OS) (Figure 1H, I) among breast cancer patients. This evidence concerns the gene UBE2T and breast cancer.